Target intelligence / Profile preview

Retinoblastoma binding protein 7, chromatin remodeling factor (RBBP7)

Target
RBBP7
Molecular classification
Chromatin remodeling factor, Histone-binding protein, WD-repeat protein family, Epigenetic regulator
01

Overview

Retinoblastoma binding protein 7 (RBBP7) is a ubiquitously expressed nuclear protein that belongs to the WD-repeat family, serving as a core component of multiple chromatin remodeling complexes. It is central to the regulation of chromatin assembly and histone modification, participating in complexes such as mSin3 co-repressor and nucleosome-remodeling factor (NURF). RBBP7 interacts directly with the tumor suppressor retinoblastoma protein (Rb), influencing cell proliferation, differentiation, and possibly tumorigenesis. The protein also has demonstrated interactions with BRCA1, indicating a potential role in DNA repair and cancer biology. RBBP7 is highly conserved and contributes to nuclear architecture and gene expression regulation via its epigenetic functions.

Other names
RB binding protein 7RBBP7RbAp46Histone-binding protein RBBP7
02

Mechanism of action

Indirect inhibition of complexes containing RBBP7, most commonly via histone deacetylase (HDAC) inhibition, resulting in altered transcriptional activity and cell cycle regulation.

03

Biological functions

Chromatin remodelingHistone modification (specifically, histone deacetylation via complex association)Regulation of cell proliferation and differentiationAssembly of chromatinComponent of various histone deacetylase complexes (e.g., mSin3 co-repressor complex)
04

Disease associations

Cancer (through interaction with retinoblastoma and BRCA1 proteins)Potential role in other proliferative or differentiation disorders (not extensively documented)Other (possible as part of wider chromatin-associated pathologies; limited explicit data)
05

Safety considerations

Direct safety data for RBBP7-targeted agents are unavailable.Safety concerns of HDAC inhibitors (the broader pathway) include myelosuppression, cardiac toxicity, and GI disturbances; these are indirect and not specific to RBBP7.Theoretical risks relate to disturbance of epigenetic regulation across multiple tissues, given the ubiquitous expression and function.
06

Interacting drugs

There are currently no well-characterized, direct drugs targeting RBBP7 as a sole agent. Instead, drugs targeting chromatin remodeling—as a general pathway—sometimes indirectly impact RBBP7 activity via HDAC or chromatin complex inhibition (e.g., HDAC inhibitors such as vorinostat or panobinostat). These do not specifically target RBBP7 but may affect complexes containing it. Direct clinical targeting of RBBP7 has not been documented.
07

Biomarkers

RBBP7 protein levels and complex association may be investigated as potential biomarkers in cancer, especially in retinoblastoma and related pathway dysregulation, but it is not established or widely used for patient selection or monitoringNo established clinical biomarker practice for RBBP7 at present

Beyond the preview

Go deeper on Retinoblastoma binding protein 7, chromatin remodeling factor (RBBP7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinoblastoma binding protein 7, chromatin remodeling factor (RBBP7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call